Barclays raised the firm’s price target on GSK to 1,575 GBp from 1,450 GBp and keeps an Equal Weight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GSK:
- GSK participates in a conference call hosted by Jefferies
- GSK says FDA approves Ojjaara for treatment of myelofibrosis
- DiaMedica appoints Ambarish Shah, Ph.D. as Chief Technology Officer
- GSK momelotinib submission for myelofibrosis accepted for review by Japan’s MHLW
- Tonix Pharmaceuticals plans to meet potential increased demand for Tosymra